Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018).

[1]  K. Fatima,et al.  Temporal Trends and Outcomes of Implantable Cardioverter Defibrillators in Systolic Heart Failure Stratified by Chronic Kidney Disease in the United States. , 2022, Current problems in cardiology.

[2]  Ò. Miró,et al.  Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology , 2022, European journal of heart failure.

[3]  M. Khan,et al.  Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018 , 2022, Circulation. Heart failure.

[4]  M. Khan,et al.  Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018. , 2021, American heart journal.

[5]  Haider J. Warraich,et al.  Association of chronic renal insufficiency with in-hospital outcomes in primary atrial fibrillation hospitalizations. , 2021, Cardiovascular revascularization medicine : including molecular interventions.

[6]  H. Jneid,et al.  Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States. , 2021, American Journal of Medicine.

[7]  A. Kichloo,et al.  Trends and Inpatient Outcomes of Primary Heart Failure Hospitalizations with a Concurrent Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (from The National Inpatient Sample Database from 2004 to 2014). , 2021, The American journal of cardiology.

[8]  D. Fliser,et al.  Cardiovascular Disease in Chronic Kidney Disease , 2021, Circulation.

[9]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. , 2021, Circulation.

[10]  G. Filippatos,et al.  Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function , 2020, Circulation.

[11]  Akshay S. Desai,et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[12]  C. Ronco,et al.  Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[13]  B. Zinman,et al.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.

[14]  Deepak L. Bhatt,et al.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.

[15]  J. Lash,et al.  CKD and ESRD in US Hispanics. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Yuling Hong,et al.  National Burden of Heart Failure Events in the United States, 2006 to 2014 , 2018, Circulation. Heart failure.

[17]  B. Zinman,et al.  Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease , 2018, Circulation.

[18]  A. Go,et al.  Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study , 2017, Journal of the American Heart Association.

[19]  C. Ronco,et al.  Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness , 2017, Blood Purification.

[20]  Navdeep K. Bhatti,et al.  Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease , 2016, Journal of the American Heart Association.

[21]  John M Lachin,et al.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. , 2016, The New England journal of medicine.

[22]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[23]  M. Tonelli,et al.  Cause of Death in Patients with Reduced Kidney Function. , 2015, Journal of the American Society of Nephrology : JASN.

[24]  L. Tavazzi,et al.  Predictors of Mortality in 6975 Patients With Chronic Heart Failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial: Proposal for a Nomogram , 2013, Circulation. Heart failure.

[25]  P. Bacchetti,et al.  White/black racial differences in risk of end-stage renal disease and death. , 2009, The American journal of medicine.

[26]  G. Fonarow,et al.  High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. , 2007, Journal of cardiac failure.

[27]  A. Go,et al.  Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study , 2006, Circulation.

[28]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.

[29]  M. Fisher,et al.  Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. , 2005, Journal of the American College of Cardiology.

[30]  Doron Schwartz,et al.  The association between congestive heart failure and chronic renal disease , 2004, Current opinion in nephrology and hypertension.

[31]  Henry T. Yu.  Progression of chronic renal failure. , 2003, Archives of internal medicine.

[32]  A. Garg,et al.  Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. , 2002, Kidney international.

[33]  W. Bloembergen,et al.  A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[35]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[36]  David C. Murray,et al.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. , 1995, Kidney international.

[37]  J. Laragh,et al.  Role of the Kidney in Congestive Heart Failure , 2012, Drugs.

[38]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  C. Leier,et al.  Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. , 1984, Circulation.